Newsroom category: Drug Injury News

LPR Attorney Cameron Stephenson Appointed to Plaintiffs’ Executive Committee in Ozempic MDL

May 9, 2024

On May 8, 2024, the U.S. District Judge Gene E.K. Pratter entered Case Management Order No. 6 establishing the expanded Leadership Structure in the “Ozempic lawsuits” [IN RE: GLUGAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RAS) PRODUCTS LIABILITY LITIGATION (MDL 3094)]. Levin Papantonio Rafferty (LPR) Attorney Cameron Stephenson was appointed to the Plaintiffs’ Executive Committee in this […]

Read More

Mississippi Supreme Court Revives Case of Man Who Died From Acetaminophen-Induced Liver Failure

February 23, 2024

Levin Papantonio Rafferty (LPR) law firm announced a 5-4 Mississippi Supreme Court decision affirming a Mississippi Court of Appeals ruling that reversed the dismissal of a wrongful death case related to acetaminophen-induced liver failure. LPR Attorney Tim O’Brien represents the widow of Marcus D. Smith, who in 2013 suffered cervical fracture and multiple rib fractures in a multi-vehicle accident […]

Read More

JPML Centralizes Suboxone Tooth Decay Lawsuits

February 6, 2024

The nationally recognized mass tort law firm Levin Papantonio Rafferty (LPR) announces that the Judicial Panel on Multidistrict Litigation (JPML) created a multidistrict litigation (MDL No. 3092) for In re: Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation. The JPML issued a Transfer Order on Friday, February 2, 2024, to centralize lawsuits in which claimants allege they were […]

Read More